202 related articles for article (PubMed ID: 15110857)
21. Structures of human carbonic anhydrase II/inhibitor complexes reveal a second binding site for steroidal and nonsteroidal inhibitors.
Cozier GE; Leese MP; Lloyd MD; Baker MD; Thiyagarajan N; Acharya KR; Potter BV
Biochemistry; 2010 Apr; 49(16):3464-76. PubMed ID: 20297840
[TBL] [Abstract][Full Text] [Related]
22. Estrone formate: a novel type of irreversible inhibitor of human steroid sulfatase.
Schreiner EP; Billich A
Bioorg Med Chem Lett; 2004 Oct; 14(19):4999-5002. PubMed ID: 15341968
[TBL] [Abstract][Full Text] [Related]
23. Development of novel steroid sulfatase inhibitors. I. Synthesis and biological evaluation of biphenyl-4-O-sulfamates.
Okada M; Nakagawa T; Iwashita S; Takegawa S; Fujii T; Koizumi N
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):141-8. PubMed ID: 14672734
[TBL] [Abstract][Full Text] [Related]
24. The nature of inhibition of steroid sulphatase activity by tibolone and its metabolites.
Raobaikady B; Day JM; Purohit A; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):229-37. PubMed ID: 15862970
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of steroid sulphatase activity via the percutaneous route: a new option for breast cancer therapy.
Purohit A; Chander SK; Woo LW; Parsons MF; Jhalli R; Potter BV; Reed MJ
Anticancer Res; 2008; 28(3A):1517-23. PubMed ID: 18630506
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of 3-benzylaminocoumarin-7-O-sulfamate derivatives as steroid sulfatase inhibitors.
Hng Y; Lin MH; Lin TS; Liu IC; Lin IC; Lu YL; Chang CN; Chiu PF; Tsai KC; Chen MJ; Liang PH
Bioorg Chem; 2020 Mar; 96():103618. PubMed ID: 32059152
[TBL] [Abstract][Full Text] [Related]
27. 4,4'-Benzophenone-O,O'-disulfamate: a potent inhibitor of steroid sulfatase.
Nussbaumer P; Bilban M; Billich A
Bioorg Med Chem Lett; 2002 Aug; 12(16):2093-5. PubMed ID: 12127511
[TBL] [Abstract][Full Text] [Related]
28. Boronic acids as inhibitors of steroid sulfatase.
Ahmed V; Liu Y; Silvestro C; Taylor SD
Bioorg Med Chem; 2006 Dec; 14(24):8564-73. PubMed ID: 16973364
[TBL] [Abstract][Full Text] [Related]
29. Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Nussbaumer P; Winiski AP; Billich A
J Med Chem; 2003 Nov; 46(23):5091-4. PubMed ID: 14584960
[TBL] [Abstract][Full Text] [Related]
30. Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity.
Wood PM; Woo LW; Labrosse JR; Trusselle MN; Abbate S; Longhi G; Castiglioni E; Lebon F; Purohit A; Reed MJ; Potter BV
J Med Chem; 2008 Jul; 51(14):4226-38. PubMed ID: 18590272
[TBL] [Abstract][Full Text] [Related]
31. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
Walter G; Liebl R; von Angerer E
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
[TBL] [Abstract][Full Text] [Related]
32. Dual aromatase-steroid sulfatase inhibitors.
Woo LW; Bubert C; Sutcliffe OB; Smith A; Chander SK; Mahon MF; Purohit A; Reed MJ; Potter BV
J Med Chem; 2007 Jul; 50(15):3540-60. PubMed ID: 17580845
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of fluorinated N-benzoyl and N-phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7-O-sulfamate as steroid sulfatase inhibitors.
Daśko M; Przybyłowska M; Rachon J; Masłyk M; Kubiński K; Misiak M; Składanowski A; Demkowicz S
Eur J Med Chem; 2017 Mar; 128():79-87. PubMed ID: 28152429
[TBL] [Abstract][Full Text] [Related]
34. Development of steroid sulfatase inhibitors.
Woo LW; Purohit A; Potter BV
Mol Cell Endocrinol; 2011 Jul; 340(2):175-85. PubMed ID: 21238537
[TBL] [Abstract][Full Text] [Related]
35. Chemical synthesis and evaluation of 17α-alkylated derivatives of estradiol as inhibitors of steroid sulfatase.
Fournier D; Poirier D
Eur J Med Chem; 2011 Sep; 46(9):4227-37. PubMed ID: 21782294
[TBL] [Abstract][Full Text] [Related]
36. A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents.
Leese MP; Hejaz HA; Mahon MF; Newman SP; Purohit A; Reed MJ; Potter BV
J Med Chem; 2005 Aug; 48(16):5243-56. PubMed ID: 16078843
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonate or sulfamate moieties as steroid sulfatase enzyme inhibitors.
El-Gamal MI; Semreen MH; Foster PA; Potter BV
Bioorg Med Chem; 2016 Jun; 24(12):2762-7. PubMed ID: 27143133
[TBL] [Abstract][Full Text] [Related]
38. 6-(2-adamantan-2-ylidene-hydroxybenzoxazole)-O-sulfamate: a potent non-steroidal irreversible inhibitor of human steroid sulfatase.
Schreiner EP; Wolff B; Winiski AP; Billich A
Bioorg Med Chem Lett; 2003 Dec; 13(24):4313-6. PubMed ID: 14643316
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and Biological Evaluation of Fluorinated 3-Phenylcoumarin-7-O-Sulfamate Derivatives as Steroid Sulfatase Inhibitors.
Demkowicz S; Daśko M; Kozak W; Krawczyk K; Witt D; Masłyk M; Kubiński K; Rachon J
Chem Biol Drug Des; 2016 Feb; 87(2):233-8. PubMed ID: 26280898
[TBL] [Abstract][Full Text] [Related]
40. Steroid sulfatase: a new target for the endocrine therapy of breast cancer.
Stanway SJ; Delavault P; Purohit A; Woo LW; Thurieau C; Potter BV; Reed MJ
Oncologist; 2007 Apr; 12(4):370-4. PubMed ID: 17470679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
